Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge—December 1st–2nd, 2021
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge—December 1st–2nd, 2021 ; volume:20 ; number:1 ; day:15 ; month:6 ; year:2022 ; pages:1-11 ; date:12.2022
Journal of translational medicine ; 20, Heft 1 (15.6.2022), 1-11, 12.2022
- Urheber
-
Burton, Elizabeth M.
Amaria, Rodabe N.
Cascone, Tina
Chalabi, Myriam
Gross, Neil D.
Mittendorf, Elizabeth A.
Scolyer, Richard A.
Sharma, Padmanee
Ascierto, Paolo A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-022-03472-x
- URN
-
urn:nbn:de:101:1-2022080921413176355903
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Burton, Elizabeth M.
- Amaria, Rodabe N.
- Cascone, Tina
- Chalabi, Myriam
- Gross, Neil D.
- Mittendorf, Elizabeth A.
- Scolyer, Richard A.
- Sharma, Padmanee
- Ascierto, Paolo A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
What have we learned from cancer immunotherapy in the last 3 years?
The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021
Highlights and summary of the 28th annual meeting of the Society for Immunotherapy of Cancer
The “Great Debate” at Immunotherapy Bridge 2022, Naples, November 30th–December 1st, 2022
Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, November 30th 2016
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd–3rd, 2020, Italy)
Melanoma: the role of surgery in the era of new therapies
Adjuvant therapy of melanoma with interferon: lessons of the past decade
Combination therapy: the next opportunity and challenge of medicine
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022)
What have we learned from cancer immunotherapy in the last 3 years?
The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021
Highlights and summary of the 28th annual meeting of the Society for Immunotherapy of Cancer
The “Great Debate” at Immunotherapy Bridge 2022, Naples, November 30th–December 1st, 2022
Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, November 30th 2016
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd–3rd, 2020, Italy)
Melanoma: the role of surgery in the era of new therapies
Adjuvant therapy of melanoma with interferon: lessons of the past decade
Combination therapy: the next opportunity and challenge of medicine
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022)
What have we learned from cancer immunotherapy in the last 3 years?
The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021
Highlights and summary of the 28th annual meeting of the Society for Immunotherapy of Cancer
The “Great Debate” at Immunotherapy Bridge 2022, Naples, November 30th–December 1st, 2022
Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, November 30th 2016
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd–3rd, 2020, Italy)
Melanoma: the role of surgery in the era of new therapies
Adjuvant therapy of melanoma with interferon: lessons of the past decade
Combination therapy: the next opportunity and challenge of medicine
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?